MyoKardia Announces Primary and All Secondary Endpoints Met in Phase 3 EXPLORER Clinical Trial of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy Read more about MyoKardia Announces Primary and All Secondary Endpoints Met in Phase 3 EXPLORER Clinical Trial of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
MyoKardia Launches New HCM Disease Awareness Website Read more about MyoKardia Launches New HCM Disease Awareness Website
FDA Approves New Treatment For a Type of Heart Failure Read more about FDA Approves New Treatment For a Type of Heart Failure
